PFIZER'S Duavive (conjugated estrogens/bazedoxifene), a novel menopausal hormone therapy, has received TGA approval for treatment of menopausal vasomotor symptoms under certain conditions - see the PI at tga.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 11 Oct 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 11 Oct 17
